Novo Nordisk and Eli Lilly are offering discounts to encourage more insurance coverage of the medicines, which carry price ...

Ozempic, Wegovy, Zepbound, and Mounjaro are but a few of the injectable drugs that are currently revolutionizing the size of ...

A Swiss pharmaceutical company hoping to cash in on the weight loss drug trend is having its dreams dashed amid new trials ...

In an unconventional alliance, North Carolina State Treasurer Dale Folwell, a Republican, spoke on Capitol Hill at a ...

Weight loss injections are essentially the opposite of pills in terms of pros and cons. They’re generally more effective and ...

Many people are doing an end-run around their doctor's office, reaching out to potentially unreliable sources that promise to ...

The injectable weight-loss drug Zepbound appears to work better in women than in men, according to a new analysis.

"Weight loss medications are not one size fits all and patients should always discuss options with a trusted medical professional," one expert told Newsweek.

In July, the U.S. Food and Drug Administration warned that people are overdosing on compounded semaglutide injectable ...

Injectable weight loss drugs are popular right now but can be hard to get because they are in short supply or too expensive ...

Wegovy, Zepbound and other cutting-edge weight-loss drugs can be tough to get these days.They’re in short supply, ...

The weight-loss market is heating up as a number of companies are looking for a way to upend the dominance of market leaders Novo Nordisk ( NVO) and Eli Lilly ( LLY) by introducing GLP-1 pills.